AL-S Pharma - Crunchbase Company Profile & Funding

Q: Where is AL-S Pharma's headquarters?

AL-S Pharma is located in Schlieren, Zurich, Switzerland.

Q: Who invested in AL-S Pharma?

AL-S Pharma has 2 investors including Neurimmune Holding And TVM Capital Life Science.

Q: When was the last funding round for AL-S Pharma?

AL-S Pharma closed its last funding round on obfuscated from a Seed round.

Overview

AL-S Pharma

Growth Score

Heat Score

Company Performance Metrics

Score

Trend

About These Metrics

AI Content may contain mistakes and is not legal, financial or investment advice.

Learn more.

Growth Score - The measure of growth based on company activity, operational metrics, and investments

Growth Trend - The change in the growth score over the given time period

Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity

Heat Trend - The change in the heat score over the given time period

Recent Milestones

Raised Funding Round

Jan 1, 1970

Lorem ipsum dolor sit amet, consectetur

Raised Funding Round

Jan 1, 1970

Lorem ipsum dolor sit amet, consectetur

+2 more milestones

See more interactive data and historical milestones on desktop for the best experience

About AL-S Pharma

CB Rank

365590

AL-S Pharma AG develops AP-101, a human monoclonal antibody targeting misfolded SOD1 for the treatment of ALS.

Founded

obfuscation

Private

Seed

Schlieren, Zurich, Switzerland

1-10

Health Care

Medical

Funding Rounds

Seed

OBF

obfuscation

Key People

Angela Genge: Chief Medical Officer

Details

Operating Status

Active

Company Type

For Profit

Predictions & Insights

Growth Insight

See this Growth Insight

AL-S Pharma is

Lorem

to be growing

Top Contributing Factors

Operations Expansion

Growth Prediction

See this Growth Prediction

Top Contributing Factors

Key Employee Changes

Unlock More with Crunchbase Pro

Full access to financial & funding data on unlimited profiles
Export up to 2k results/month for analysis
Track market signals on competitors, products, and R&D
Preview private company insights and predictions

Financials

Company Funding

Funding Rounds

Investors

Number of Funding Rounds

Unlock company funding data, including rounds, dates, amounts, and investors.

Announced Date	Transaction Name	Number of Investors	Money Raised	Lead Investors	Funding Type
obfuscated obfuscation	Seed Round - AL-S Pharma	2	obfuscated obfuscation	—	Seed
obfuscated obfuscation	Seed Round - AL-S Pharma	2	obfuscated obfuscation	—	Seed
obfuscated obfuscation	Seed Round - AL-S Pharma	2	obfuscated obfuscation	—	Seed
obfuscated obfuscation	Seed Round - AL-S Pharma	2	obfuscated obfuscation	—	Seed
obfuscated obfuscation	Seed Round - AL-S Pharma	2	obfuscated obfuscation	—	Seed

Funding Rounds

Number of Funding Rounds

Unlock company funding data, including rounds, dates, amounts, and investors.

Announced Date	Transaction Name	Number of Investors	Money Raised	Lead Investors	Funding Type
obfuscated obfuscation	Seed Round - AL-S Pharma	2	obfuscated obfuscation	—	Seed
obfuscated obfuscation	Seed Round - AL-S Pharma	2	obfuscated obfuscation	—	Seed
obfuscated obfuscation	Seed Round - AL-S Pharma	2	obfuscated obfuscation	—	Seed
obfuscated obfuscation	Seed Round - AL-S Pharma	2	obfuscated obfuscation	—	Seed
obfuscated obfuscation	Seed Round - AL-S Pharma	2	obfuscated obfuscation	—	Seed

Investors

Unlock company funding data, including rounds, dates, amounts, and investors.

Investor Name	Lead Investor	Funding Round	Partners
Neurimmune Holding	—	Seed Round - AL-S Pharma	—
Neurimmune Holding	—	Seed Round - AL-S Pharma	—
Neurimmune Holding	—	Seed Round - AL-S Pharma	—
Neurimmune Holding	—	Seed Round - AL-S Pharma	—
Neurimmune Holding	—	Seed Round - AL-S Pharma	—